HIV seroconverting donors delay their return: screening test implications
- 1 April 2002
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 42 (4) , 414-421
- https://doi.org/10.1046/j.1525-1438.2002.00084.x
Abstract
BACKGROUND: The yield of HIV p24 antigen testing implemented in March 1996 has been lower than projected. One possible explanation is that HIV seroconverting donors delay their return because of the recent practice of risk behaviors and/or signs and symptoms associated with primary infection. STUDY DESIGN AND METHODS: From a database of 6.8‐million allogeneic donations collected at five U.S. blood centers from 1991 to 1997, 49 HIV, 21 HCV, 32 HTLV, and 44 HBsAg seroconverters with at least three donations were identified. A statistical method was developed to investigate whether the time between a donor's last negative donation and their positive donation was significantly longer than expected based on their previous return history. RESULTS: HIV seroconverters returned on average 42 percent later than expected (p < 0.01). Although not significant, HCV seroconverters donated on average 43 percent earlier than expected. HTLV and HBsAg seroconverters did not appear to change their donation pattern around the time of seroconversion. Sixty‐three percent of the HIV seroconverters later acknowledged practicing a high‐risk behavior. CONCLUSIONS: HIV seroconverters delay their return around the time of seroconversion and are thus less likely to be recently infected. Unique among HIV seroconverters, this observation provides a possible explanation for the lower than expected yield of HIV p24 antigen testing and suggests that NAT may have a similar low yield.Keywords
This publication has 20 references indexed in Scilit:
- Motivations to donate blood: demographic comparisonsTransfusion, 2002
- Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseasesTransfusion, 2000
- The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infectionTransfusion Medicine Reviews, 1997
- Primary infection by type 1 human immunodeficiency virus: diagnosis and prognosisPublished by Oxford University Press (OUP) ,1997
- The Retrovirus Epidemiology Donor Study (REDS): rationale and methodsTransfusion, 1995
- Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donorsTransfusion, 1995
- Primary Human Immunodeficiency Virus Type 1 Infection: Review of Pathogenesis and Early Treatment Intervention in Humans and Animal Retrovirus InfectionsThe Journal of Infectious Diseases, 1993
- Epidemiology of hepatitis BThe Pediatric Infectious Disease Journal, 1993
- Characterization of the acute clinical illness associated with human immunodeficiency virus infectionArchives of internal medicine (1960), 1988
- Aquisition of hepatitis-associated antigen. Clinical features in young adultsJAMA, 1971